BiotechTube
Microarrays

Microarrays

Huntsville, United States· Est.
microarrays.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $24.2M

Overview

Microarrays Inc. is a long-standing, privately-held service provider in the genomics and proteomics space, leveraging microarray technology to support research and diagnostic development. Its business model is centered on fee-for-service lab work, custom array fabrication, and assay development services for clients in academia, biopharma, and diagnostics. The company's location within the HudsonAlpha Institute provides a collaborative ecosystem, but it operates in a mature market segment facing competition from newer sequencing and high-throughput technologies. Its focus on quality parameters and regulatory compliance positions it for specialized diagnostic partnerships.

DiagnosticsGenetics & Genomics

Technology Platform

Custom microarray fabrication and analysis platform for DNA, protein, peptide, antibody, and antigen applications. Includes proprietary printing methodologies, surface chemistries, and stringent quality control (QC) protocols for research and diagnostic assay development.

Funding History

3
Total raised:$24.2M
Series B$15M
Series A$8M
Seed$1.2M

Opportunities

Growing demand for multiplexed, targeted diagnostic tests in oncology and personalized medicine creates a market for robust array-based assays.
The company's FDA compliance expertise positions it well as a development and manufacturing partner for diagnostic companies.
Expansion of proteomics services (protein/antibody arrays) addresses a market with less direct competition from sequencing technologies.

Risk Factors

The core microarray technology faces perception challenges and competition from next-generation sequencing and other multiplexed platforms.
Revenue stability is vulnerable to dependence on a limited number of large client projects or partnerships.
Operating in a regulated (FDA) space alongside clients introduces regulatory and reputational risk.

Competitive Landscape

Microarrays Inc. competes with large life science tools companies like Thermo Fisher Scientific, Agilent Technologies, and Illumina who offer standardized array products. It also faces competition from broader service providers (CROs/CDMOs) and the overarching technological shift towards sequencing. Its competitive edge lies in deep customization, focused expertise, high-touch service, and specialized QC for diagnostic development.

More companies in Diagnostics & Precision Medicine →More companies in United States →